Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
First Analysis
AddedFeb 13, 2024
UpdatedJun 28, 2026
First Analysis

First Analysis

Operating

First Analysis, a seasoned investment banking firm, serving emerging and established companies since 1981.

Location
Chicago, IL, US
Founded
1981
Firm
Compare
Portfolio
Employees
Website

Investments

Stamus Networks
Stamus Networks

Total Raised

$7.5M

Rounds

2

Series A$6MAugust 2023
CoolR Group
CoolR Group

Total Raised

$10.1M

Rounds

4

Series Unknown$10MOctober 2022
Drive My Way
Drive My Way

Total Raised

$4.5M

Rounds

2

Series A$4.4MSeptember 2022
EdgeIQ
EdgeIQ

Total Raised

$8.8M

Rounds

2

Series A$8.5MJuly 2022
Fortress Information Security
Fortress Information Security

Total Raised

$160M

Rounds

4

Series C$125MApril 2022
Series B$16MFebruary 2019
Insellerate
Insellerate

Total Raised

$6M

Rounds

2

Private EquityFebruary 2022
Checkpoint Surgical
Checkpoint Surgical

Total Raised

$44.7M

Rounds

8

Series Unknown$16MAugust 2021
Series D$8.8MSeptember 2018
Series C$7.5MDecember 2015
SmartCommerce
SmartCommerce

Total Raised

$29.5M

Rounds

9

Series B$13MApril 2021
Visage
Visage

Total Raised

$10.9M

Rounds

8

Series A$7MMarch 2021
Tracer
Tracer

Total Raised

$29.6M

Rounds

5

Series C$12.2MJanuary 2021
Series B$10MMarch 2019
Vida Diagnostics
Vida Diagnostics

Total Raised

$33.2M

Rounds

8

Series C$11MMarch 2020
Blue Medora
Blue Medora

Total Raised

$32.5M

Rounds

5

Series B$8MOctober 2017
ViralGains
ViralGains

Total Raised

$28.7M

Rounds

7

Series B$13.5MSeptember 2017
Yello
Yello

Total Raised

$89.4M

Rounds

5

Series C$31MJune 2017
Series B$4.2MAugust 2016
Series B$5MNovember 2015
Scale Computing
Scale Computing

Total Raised

$202.8M

Rounds

11

Series E$18MJuly 2015
Series Unknown$7MJune 2014
Courtagen Life Sciences
Courtagen Life Sciences
Acquired

Total Raised

$65M

Rounds

9

Private Equity$20MJuly 2015
Sonoma Orthopedic Products
Sonoma Orthopedic Products

Total Raised

$60.5M

Rounds

7

Series E$12MDecember 2014
VisiQuate
VisiQuate

Total Raised

$70.2M

Rounds

7

Series C$6MJuly 2014